• Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Growth Equity non VC
Total Funding-

Recent News about Elsevier

Edit
More about Elsevierinfo icon
Edit

Elsevier is a global leader in providing information and analytics solutions to researchers, clinicians, and educators. Operating in the academic and healthcare sectors, Elsevier offers a wide range of products and services designed to advance knowledge and improve outcomes. The company serves academic institutions, research organizations, and healthcare providers by offering research platforms like Scopus and ScienceDirect, clinical solutions such as ClinicalKey, and educational tools like Evolve. Elsevier's business model revolves around subscription-based access to its databases, journals, and digital tools, as well as transactional sales of individual articles and books. The company generates revenue through subscriptions, licensing agreements, and sales of its digital content. Elsevier also engages in partnerships to develop innovative solutions addressing global challenges in research and healthcare.

Keywords: information, analytics, research, clinical solutions, education, Scopus, ScienceDirect, ClinicalKey, academic, healthcare.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Elsevier

Edit
Collexis
ACQUISITION by Elsevier Jun 2010
Mendeley
ACQUISITION by Elsevier Apr 2013
Infermed
ACQUISITION by Elsevier Jul 2015
Professional Development Software
ACQUISITION by Elsevier Apr 2009
Newsflo
ACQUISITION by Elsevier Jan 2015
Elsevier / MEDai
ACQUISITION by Elsevier Jan 2008
Plum Analytics
ACQUISITION by Elsevier Feb 2017
3D4Medical.com
ACQUISITION by Elsevier Nov 2019
Aureus sciences / aureus pharma
ACQUISITION by Elsevier Jan 2013
Atira
ACQUISITION by Elsevier Aug 2012
View 12 more